These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 21988298)

  • 1. T-cell-mediated and humoral approaches to universal influenza vaccines.
    Sommerfelt MA
    Expert Rev Vaccines; 2011 Oct; 10(10):1359-61. PubMed ID: 21988298
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral and cell mediated immune response to bivalent influenza A/NJ/76 and A/Vict/75 vaccine in renal allograft recipients.
    Rytel MW; Niebojewski RA; Rosenkranz MA; Sedmak G
    Dev Biol Stand; 1977 Jun 1-3; 39():225-30. PubMed ID: 342308
    [No Abstract]   [Full Text] [Related]  

  • 3. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U; Tzadok S; Amir S; Mandelboim M; Mendelson E; Wigler I; Sarbagil-Maman H; Paran D; Caspi D; Elkayam O
    Vaccine; 2011 Feb; 29(8):1643-8. PubMed ID: 21211590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
    Unanov SS; Yuminova NV; Akopova II
    Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced immunogenicity of influenza vaccines in HIV-infected compared with uninfected pregnant women is associated with regulatory T cells.
    Richardson K; Weinberg A
    AIDS; 2011 Mar; 25(5):595-602. PubMed ID: 21368590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosenescence: role and measurement in influenza vaccine response among the elderly.
    Targonski PV; Jacobson RM; Poland GA
    Vaccine; 2007 Apr; 25(16):3066-9. PubMed ID: 17275144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults.
    Guthrie T; Hobbs CG; Davenport V; Horton RE; Heyderman RS; Williams NA
    J Infect Dis; 2004 Dec; 190(11):1927-35. PubMed ID: 15529256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better influenza vaccines for older people: what will it take?
    McElhaney JE; Dutz JP
    J Infect Dis; 2008 Sep; 198(5):632-4. PubMed ID: 18652548
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.
    van Assen S; de Haan A; Holvast A; Horst G; Gorter L; Westra J; Kallenberg CG; Telgt DS; Palache AM; Giezeman KM; Bijl M
    Clin Immunol; 2011 Nov; 141(2):161-8. PubMed ID: 21889412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
    Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI
    Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxic T-cell response to influenza A subunit vaccine in patients with type 1 diabetes mellitus.
    Diepersloot RJ; Bouter KP; van Beek R; Lucas CJ; Masurel N; Erkelens DW
    Neth J Med; 1989 Aug; 35(1-2):68-75. PubMed ID: 2789342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against influenza viruses: current status.
    Ghendon Y
    Adv Biotechnol Processes; 1990; 14():159-201. PubMed ID: 2222833
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM; Holmes TH; Stamatis S; Tu W; He XS; Bouvier N; Kemble G; Greenberg HB; Lewis DB; Arvin AM; Dekker CL
    Pediatr Infect Dis J; 2007 Feb; 26(2):107-15. PubMed ID: 17259871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic T-cell immunity as a target for influenza vaccines.
    Müllbacher A; Lobigs M; Alsharifi M; Regner M
    Lancet Infect Dis; 2006 May; 6(5):255-6. PubMed ID: 16631540
    [No Abstract]   [Full Text] [Related]  

  • 19. Serial re-challenge with influenza vaccine as a tool to study individual immune responses.
    Vallerskog T; Gaines H; Feldman A; Culbert E; Klareskog L; Malmström V; Trollmo C
    J Immunol Methods; 2008 Dec; 339(2):165-74. PubMed ID: 18835393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral and cellular immunity in influenza virus infection].
    Werner GH
    Bull Acad Natl Med; 1993 Oct; 177(7):1263-72; discussion 1272-3. PubMed ID: 8149262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.